YEEDO News
-
National Hypertension Day | Let's talk about the research and development status of hypertension drugs
China has a large population of hypertensive patients, currently exceeding 270 million yuan. In 2013, the direct economic burden caused by hypertension reached 210.3 billion yuan, accounting for 6.61% of the total health costs in China. It causes a huge national medical burden.2020-10-08
According to the 2018 Revision of Chinese Guidelines for the Prevention and Treatment of Hypertension, the important risk factors of hypertension in Chinese population mainly include: high sodium, low potassium diet, overweight and obesity, excessive drinking, long-term mental stress and age, family history of hypertension, physical inactivity, diabetes, dyslipidemia and other causes.
-
Sheng Shi Hua birthday, family Tongqing | Yeedozencom wish you a happy double festival!
2020-10-01 -
New rules, new starting point, solution to the innovation number of the pharmaceutical industry look here! Yiduzhengkang Meet You: The 4th China Forum on Innovative Drugs and Editorial Board Meeting of China Journal of New Drugs (October 16-18, 2020)
In October, the "2020 Fourth China Forum on Innovative Drugs and Editorial Board of China Journal of New Drugs" sponsored by China Journal of New Drugs will be held in Beijing Yichuang International Convention and Exhibition Center. As a co-organizer, Yeedozencom sincerely invites you to attend the event (October 16-18, 2020)!2020-09-25 -
Today's Autumn Equinox
2020-09-22 -
Alzheimer's Day
2020-09-21 -
News Express – Jiangsu Value Pharmaceutical Services Co., LTD.
Jiangsu Value Pharmaceutical Services Co., LTD. has won full scores in the external quality assessment by National Center for Clinical Laboratories (NCCL, China) for four consecutive years.2020-08-25